Granules India informs about Outcome of Board Meeting

23 Jul 2015 Evaluate

Granules India has informed that the Board of Directors of the Company at its meeting held on July 23, 2015, has approved the investment of up to Rs. 20 Crores in GIL Lifesciences, a wholly owned Indian Subsidiary of the Company, approved the issue of 1,86,56,000 warrants on preferential basis to Tyche Technologies, a promoter group Company, subject to approval of the members, at a price arrived at in accordance with the SEBI (ICDR) Regulations, 2009 and fixed the date of Extra-Ordinary General Meeting of the members of the Company on August 24, 2015 to consider the issue of warrants on preferential basis to Promoter Group Company.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

564.95 -6.25 (-1.09%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×